Evidence map›Paper›PMID 37671468›Full record

ReviewHuman vaccines & immunotherapeutics2023

The impact of the COVID-19 pandemic on vaccination uptake in the United States and strategies to recover and improve vaccination rates: A review.

Luke Cunniff, Elif Alyanak, Alessandra Fix, Mara Novak, Megan Peterson, Kate Mevis, Amanda L Eiden, Alexandra Bhatti

Open access · goldAbstract readReview
In one paragraph

Review in Human vaccines & immunotherapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Post-Pandemic Surge in Complications of Acute Otitis Media.Turkish archives of otorhinolaryngology · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Luke CunniffGlobal Vaccines Public Policy and Partnerships, Merck & Co., Inc., . Rahway, NJ, USA.
Elif AlyanakAvalere Health, Washington, DC, USA.ORCID 0000-0002-5894-3904
Alessandra FixAvalere Health, Washington, DC, USA.
Mara NovakAvalere Health, Washington, DC, USA.
Megan PetersonAvalere Health, Washington, DC, USA.
Kate MevisGlobal Vaccines Public Policy and Partnerships, Merck & Co., Inc., . Rahway, NJ, USA.
Amanda L EidenCenter for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Rahway, NJ, USA.
Alexandra BhattiGlobal Vaccines Public Policy and Partnerships, Merck & Co., Inc., . Rahway, NJ, USA.
Merck & Co., Inc., Rahway, NJ, USA (United States) · USPrevea Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic disrupted routine healthcare delivery, causing declines in CDC-recommended vaccination rates across the life-course in the United States (US). Ensuring protection against disease outbreaks and associated morbidity and mortality depends on improving vaccine coverage rates (VCRs) and uptake. The authors conducted a targeted literature review to assess the pandemic's effects on routine vaccination rates across different populations, evaluating VCR recovery and improvement efforts. The review highlights articles published with data measuring or evaluating VCR decline across the US during the COVID-19 pandemic from January 2020 to April 2022, associated health impacts, and policy and programmatic strategies to recover routine VCRs. While vaccination rates stagnated or declined across some populations pre-pandemic, the review indicated there were further VCR declines in 2020 and 2021 compared to 2019 across numerous CDC-recommended vaccines, ages, and geographies, with some vaccines and sub-populations disproportionally impacted. The review additionally identified declines in patient healthcare visit frequency and increases in morbidity and mortality associated with vaccine-preventable disease (VPD) complications. Reviewed publications highlighted multifaceted strategies that could aid in recovering VCRs. Overall, findings demonstrate a significant reduction in VCRs across all age groups and highlight promising solutions to inform vaccine uptake efforts and ensure broader protection against VPDs.

Indexed as

COVID-19PandemicsDisease OutbreaksGeographyHumansUnited StatesVaccinationcatch-upCOVID-19missed dosespandemicroutine vaccinationvaccination recovery

Identifiers

PMID37671468
PMCPMC10484032
OpenAlexW4386466469

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.